Privia Health Group, Inc. (NASDAQ:PRVA – Get Rating) CEO Matthew Shawn Morris sold 44,340 shares of the firm’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $28.48, for a total transaction of $1,262,803.20. Following the sale, the chief executive officer now directly owns 121,739 shares in the company, valued at approximately $3,467,126.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Privia Health Group Stock Performance
Shares of NASDAQ PRVA opened at $27.72 on Friday. The firm has a market capitalization of $3.19 billion, a P/E ratio of -252.00, a PEG ratio of 5.68 and a beta of 0.79. Privia Health Group, Inc. has a one year low of $17.99 and a one year high of $44.64. The company’s fifty day moving average is $26.08 and its two-hundred day moving average is $29.50.
Wall Street Analysts Forecast Growth
PRVA has been the topic of a number of research analyst reports. Truist Financial cut their price objective on shares of Privia Health Group to $41.00 in a report on Thursday, November 17th. The Goldman Sachs Group initiated coverage on shares of Privia Health Group in a report on Friday, February 3rd. They issued a “buy” rating and a $32.00 target price on the stock. BTIG Research cut their target price on shares of Privia Health Group from $45.00 to $40.00 in a report on Monday, January 9th. SVB Leerink cut their target price on shares of Privia Health Group from $46.00 to $39.00 and set an “outperform” rating on the stock in a report on Friday, November 11th. Finally, Stifel Nicolaus initiated coverage on shares of Privia Health Group in a report on Thursday, December 8th. They issued a “buy” rating and a $28.00 target price on the stock. Fourteen research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $38.73.
Institutional Investors Weigh In On Privia Health Group
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
- Get a free copy of the StockNews.com research report on Privia Health Group (PRVA)
- Fossil Group: Should You Bet On Consumer Discretionary In 2023?
- BJ’s Wholesale Club Stock Moves Higher After Strong Results
- Monthly Realty Income is About to Get Bigger
- 3 Large Cap Dividend Challengers for Millennial Investors
- Sea Ltd Is On The Verge Of A 100% Rally, Should You Buy?
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.